Polynucleotides encoding stem cell growth factor-like polypeptides
US7317099B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2000 |
| Grant date | Jan 8, 2008 |
| Priority date | — |
| Expiry date | Oct 23, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries prepared from human fetal liver spleen, ovary, adult brain, lung tumor, spinal cord, cervix, ovary, endothelial cells, umbilical cord, lymphocyte, lung fibroblast, fetal brain, and testis. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.